
Migrasaf Tablet
Marketer
SAF Fermion Ltd
Salt Composition
Domperidone (10mg) + Flunarizine (5mg) + Paracetamol (325mg)
Overview Migrasaf Tablet
Cephalease tablets are a prescription medication for migraine management. This medication inhibits pain and fever signals associated with migraine episodes, and it counteracts brain chemicals that induce nausea and vomiting. Cephalease should be taken on an empty stomach, following your doctor's prescribed dosage and duration. Your individual dosage will depend on your response and the severity of your migraines. Continue the prescribed treatment; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your physician of all other medications you are using, as interactions are possible. Common, usually temporary, side effects include weight increase and dry mouth. Report any concerning side effects immediately. Drowsiness may occur; avoid driving or tasks demanding concentration until its effects are known. Alcohol consumption should be avoided due to potential drowsiness intensification. Effective migraine management involves identifying personal triggers, such as red wine, caffeine withdrawal, stress, or missed meals. Keeping a diary documenting activities, diet, and stressors preceding migraine attacks can help in this identification. Before commencing treatment, inform your doctor if you are pregnant, planning pregnancy, breastfeeding, or have liver disease.
Uses of Migrasaf Tablet
Severe headache
Major Benefits of Migrasaf Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Migrasaf Tablet on an empty stomach.
Common Side effects of Migrasaf Tablet:
- Weight gain
- Drowsiness
- Dryness in mouth
How to use Migrasaf Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Migrasaf Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer Migrasaf on an empty stomach.
How Migrasaf Tablet works:
Migrasaf tablets contain Domperidone, Flunarizine, and Paracetamol, a three-drug formulation designed to alleviate migraine attacks accompanied by nausea and vomiting. Domperidone, an antiemetic and prokinetic agent, counteracts the effects of dopamine, a neurotransmitter triggering nausea and vomiting. Flunarizine, a calcium channel blocker, mitigates migraine by preventing vasoconstriction in the head. Paracetamol, an analgesic and antipyretic, reduces pain and fever by inhibiting the release of pain-signaling neurochemicals in the brain.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Migrasaf Tablet is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Use of Migrasaf Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Consult your physician for advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Migrasaf Tablet use while breastfeeding is absent. Seek your physician's advice.
DrivingUNSAFE
Taking Migrasaf tablets might reduce awareness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, Migrasaf Tablet is likely safe. Current evidence indicates dose modification may not be necessary, however, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Migrasaf Tablet cautiously, potentially requiring dosage modification under medical supervision. Migrasaf Tablet is contraindicated in those with severe or active liver disease.
What if you forget to take Migrasaf Tablet :
Should you forget to take a Migrasaf Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Migrasaf Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
